Back
ESC Professional Premium Access

Empagliflozin and dapagliflozin increase Na current in human cardiomyocytes

Session: Mechanisms of ventricular arrhythmias
Topic: Ion Channels, Electrophysiology
Speaker: Professor R. Caballero (Madrid, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Professor Ricardo Caballero

Complutense University of Madrid, Madrid (Spain)
0 follower

7 more presentations in this session

Synapsin 2 regulates NCX1 trafficking and is down-regulated in the failing myocardium, which increases the risk of ventricular arrhythmia and heart failure mortality

Speaker: Doctor A. Ottesen (Nordbyhagen, NO)

Access
Abstract
Slides
Like
Thumbnail

Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

Speaker: Doctor T. Kadosaka (Sapporo, JP)

Access
Abstract
Slides
Like
Thumbnail

Disease-associated calmodulin mutations disrupt L-type Ca2+ channel (Cav1.2) activity and CaMKIIdelta phosphorylation in long QT syndrome

Speaker: Assistant Professor N. Helassa (Liverpool, GB)

Access
Abstract
Slides
Like
Thumbnail

Long QT syndrome-associated calmodulin mutations and their interactions with the Kv7.1 voltage-gated potassium channel

Speaker: Mr L. McCormick (Leeds, GB)

Access
Abstract
Slides
Like
Thumbnail

Utility of in vivo zebrafish cardiac assay to predict the functional impact of KCNQ1 variants

Speaker: Mr S. Cui (Kanazawa, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Mechanisms of ventricular arrhythmias

Speakers: Professor R. Caballero, Doctor A. Ottesen, Doctor T. Kadosaka, Assistant Professor N. Helassa, Mr L. McCormick...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources